M&A Healthcare Advisors Fall 2022 Webinar – Transaction Support Roles

The M&A Healthcare Advisors’ Fall Webinar commenced with a warm welcome extended to all attendees. Hosted by Mark Thomas, co-founder of M&A Healthcare Advisors, the event promised an insightful discussion centered around transaction Port. Joining Mark as a co-host was Andre Ulloa, another esteemed co-founder of the advisory firm. Before delving into the main agenda, Mark took a moment to introduce M&A Healthcare Advisors to those unfamiliar with their work. As a boutique M&A advisory firm focused on lower middle-market healthcare clients, the company specializes in sell-side representation, hourly M&A consulting, and expert valuations. With a wealth of experience and successful transactions under their belt, the team at M&A Healthcare Advisors understands the various elements that contribute to the seamless execution of healthcare deals. Mark proceeded to introduce the four distinguished guests who would be sharing their insights throughout the webinar: Shannon, Jack, Doug, and Mike. Each guest possessed a unique background and expertise, making them valuable contributors to the conversation. Their presence exemplified the diverse perspectives necessary for a comprehensive exploration of the topics at hand.

Recent Episodes

Casey Brown didn’t grow up thinking she would become an entrepreneur. She grew up in a blue-collar family where money was always tight — close enough to the edge that the fear of poverty shaped many of her early decisions. That fear led her into engineering, into corporate America, and eventually into a moment…

In this episode of Care Anywhere, host Lea Sims sits down with Nigerian nurse entrepreneur and advocate Obafemi Arowosegbe to discuss leadership, mentorship, and the future of nursing in Africa. While still a nursing student, Obafemi founded the Nightingale Summit, a growing conference designed to empower nursing students and early-career nurses with leadership skills,…

The rapid expansion of precision medicine, biologics, and targeted cancer therapies is transforming oncology—but it’s also overwhelming a system not built to keep pace. In the U.S., cancer drugs now account for some of the highest-cost treatments in healthcare, and with that has come a surge in prior authorization requirements and denials. Studies suggest physicians…